Faeth Therapeutics, Inc. - Common Stock (FTH)
Price History
Jun 24, 2026 — Aug 10, 2026Investment Snapshot
- P/B of 3.64 — trading above book value
- Piotroski F-Score 2/9 — signs of financial weakness
- Loss-making — negative ROE of -113.2%
Faeth Therapeutics, Inc. - Common Stock (FTH) is a publicly traded company, listed on the NASDAQ , with a market capitalisation of $630 million . Key value metrics: P/B ratio 3.64, Piotroski F-Score 2 out of 9 .
Value Score
Key Metrics
Faeth Therapeutics, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, FTH shows a weak Piotroski F-Score of 2/9, a signal of deteriorating financial health, and negative return on equity of -113.2%.
StockPik's composite Value Score for FTH is 35/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
FTH shows earnings growing at 30%.